Subspecialties

Across medicine, far fewer clinical trials report positive results these days. Whether the demise of sharp scientific practices or the lack of low-hanging fruit – does it apply to ophthalmology?

Looking at vitreous samples allows us to determine which proteins are involved in the disease process, and to what degree

There’s currently an unmet need for effective interventions in early-stage retinal degenerative diseases – before vision is lost. Can three-nanosecond pulse laser therapy meet that need?

Direct visualization delivery of bevacizumab in pseudophakic eyes for the treatment of subretinal neovascularization

The path to truly effective AMD therapies is long and requires us to recognize that it’s not a single disease entity: toil and teamwork are needed to triumph

Sitting Down With...Patricia A. D’Amore, Director, Howe Laboratory; Director of Research, Schepens EyeResearch Institute, and Charles L. Schepens Professor of Ophthalmology, Harvard Medical School, Massachusetts, USA.

Heidelberg Engineering will offer a preview of its cataract and refractive imaging platform* during this year’s Congress of the ESCRS in Barcelona. The platform is based on an upgradable, modular design, which allows to configure each product to the specific diagnostic workflow in a practice or clinic. Main options include: IOL biometry, corneal topography/tomography, anterior segment biometry and anterior segment imaging.

Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology.

Five Things We Learned This Month

Can the combination of 360° haptics and a novel protective membrane, which emulates the pattern found on shark skin, in a single IOL prevent PCO and make YAG laser capsulotomies a thing of the past?